Abstract | BACKGROUND: The outcome of intermediate-stage hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) is greatly heterogeneous. Current means for predicting HCC response to TACE are lacking. PURPOSE: To investigate whether the combination of parameters derived from amide proton transfer ( APT) and intravoxel incoherent motion (IVIM) imaging, and morphological characteristics of tumor can establish a better prediction model than the univariant model for HCC response to TACE. STUDY TYPE: Prospective. SUBJECTS: 56 patients with intermediate-stage HCC (50 males and six females). FIELD STRENGTH/SEQUENCES: 3.0T; T2 -weighted-fast spin echo, 3D liver acquisition with volume flex, single-shot fast spin echo-planar imaging (EPI), spin echo-EPI. ASSESSMENT: Pretreatment APT signal intensities (SIs), apparent diffusion coefficient (ADC), true molecular diffusion coefficient (D), pseudodiffusion coefficient (D*), and perfusion fraction (f) for tumor, peritumoral, and normal tissues were measured. Follow-up MRI scanning was performed, and the patients were classified as responders or nonresponders based on the modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria. STATISTICAL TESTS: The imaging parameters were compared among the three tissues and between the two groups using analysis of variance (ANOVA) or two-sample t-test. The prediction model's variables were derived from univariate and multivariate logistic regression analyses. Receiver operating characteristic (ROC) curve analysis was used to explore the predictive performance. RESULTS: Based on the logistic regression analysis results, we established a prediction model that integrated the APT SI and D values in the tumor tissue and the tumor size. ROC analyses revealed that the model was better able to predict tumor response to TACE (area under the ROC curve = 0.851) than the individual parameters on their own. DATA CONCLUSION: A prediction model incorporating pretreatment APT SI, D in the tumor tissue and tumor size may be useful for predicting the response of intermediate-stage HCC to TACE. LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY: Stage 1 J. MAGN. RESON. IMAGING 2020;52:1657-1667.
|
Authors | Fei Jia, Baolin Wu, Ruifang Yan, Lei Li, Kaiyu Wang, Dongming Han |
Journal | Journal of magnetic resonance imaging : JMRI
(J Magn Reson Imaging)
Vol. 52
Issue 6
Pg. 1657-1667
(12 2020)
ISSN: 1522-2586 [Electronic] United States |
PMID | 32424881
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 International Society for Magnetic Resonance in Medicine. |
Topics |
- Carcinoma, Hepatocellular
(diagnostic imaging, therapy)
- Chemoembolization, Therapeutic
- Diffusion Magnetic Resonance Imaging
- Female
- Humans
- Liver Neoplasms
(diagnostic imaging, therapy)
- Male
- Prospective Studies
|